Vinona Bhatia has a passionate interest in increasing early detection of cancer and improving access to cancer treatment for people in East Africa. Vinona is a board certified Medical Oncologist who completed her fellowship training at the University of California, San Francisco (UCSF). Her specialty focus was in breast cancer and in cancers related to HIV. She has practiced at Kaiser Permanente and at San Francisco General Hospital where she cared for many indigent patients. From 2004–2006, Vinona was the clinical trial manager for a randomized controlled trial in Kampala, Uganda. Vinona recently completed her Masters in Public Health at Harvard with a thesis entitled the Morphine Gap in the Developing World: A measure of the global morphine need for patients with Cancer or HIV. Originally from the Midwest, Vinona loves the Bay Area and has been there for almost nine years. She loves to bike, swim, and hike, in addition to doing yoga and pilates regularly. She has participated in five triathlons as well as cycling fundraisers for a variety of charities. Amongst her other favorite pastimes are traveling to exotic places, attending wine-tastings, learning French, and spending quality time with friends and family.
Hilary Billings is a brand strategy consultant who specializes in creating lifestyle brands. She has developed new brands and brand extensions for large companies such as Wal-Mart, Hallmark, and Harrah’s Casino Hotels, as well as defining brand strategies for startup companies and micro enterprises such as World of Good. Ms. Billings co-founded red envelope and developed the W hotel brand for Starwood hotels and resorts. She served in a variety of roles at pottery barn, including vice president of product development and design. Ms. Billings currently serves on the corporate boards of Peet’s Coffee & Tea, Design Within Reach, Tea Collection, and Chef’s Catalog. She holds a B.A from Brown University in Art History and English.
Laura J. Frost is co-founder and partner of Global Health Insights, a research and consulting group specializing in qualitative and policy research for global health. She holds a Doctorate of Science and a MPH in International Health from the Harvard School of Public Health, and a MALD from the Fletcher School at Tufts University. She has over fifteen years of experience in global health and development and has worked with many different organizations on a range of issues including access to health technologies, public-private partnerships, health financing, and agenda setting. She has co-authored a book (with Michael R. Reich) called Access: How Do Good Technologies Get to Poor People in Poor Countries? (Cambridge, MA: Harvard Center for Population and Development Studies, 2008). Laura is currently an Adjunct Lecturer in Population and Family Health at Columbia University’s Mailman School of Public Health. She is a Global Health Affiliate for FSG Social Impact Consultants and a board member of MS SoftServe. Previously, she was Lecturer in Public & International Affairs at Princeton University’s Woodrow Wilson School and Lecturer of Research Methods and Global Health at University College Cork in Ireland. Laura has lived and worked in east, central, and southern Africa and worked with non-governmental organizations on community-based health programs in relief and development contexts.
Dr. Meg O’Brien is an epidemiologist who has been working in healthcare delivery in resource-limited settings for 15 years. She is currently the Director of the Global Access to Pain Relief Initiative (GAPRI), a program to improve the availability of essential pain medicines. Meg began her career in malaria vaccine development at Georgetown University and then worked as a biostatistical consultant at Statistics Collaborative Inc. She completed her doctorate in epidemiology at the Tulane School of Public Health and Tropical Medicine, serving as the chief epidemiologist of a large HIV treatment clinic and on the research faculty of the medical school at Louisiana State University. Meg then spent three years in Tanzania, opening up six HIV treatment clinics as part of the rollout of the US government’s PEPFAR program, while completing a postdoctoral fellowship at the Harvard School of Public Health. Before joining GAPRI, she spent five years as the research director of the Center for Strategic HIV Operations Research at the Clinton Health Access Initiative. In this role, Meg worked with governments to improve the pace and efficiency of HIV treatment scale-up and led the development of drug forecasts and quantitative models.
Kristin Peterson is the Co-Founder and CEO of Inveneo, a non-profit social enterprise focusing on Information and Communications Technologies (ICTs) in rural areas throughout the developing world. With more than 18 years of business and new market development experience, primarily from the technology and communications industries, Kristin has been responsible for strategy, partnership and support development since Inveneo’s inception in 2004. She has led Inveneo’s efforts to deliver education, healthcare, economic development and relief projects in more than 25 Sub-Saharan African and South Asian countries, touching the lives of over 1,500,000 people with life-impacting ICTs. Prior to Inveneo Kristin was VP of Marketing at an enterprise IP services technology start-up, and she founded Velocity Consulting, an organization that provided go-to-market guidance to a range of networking, wireless and VoIP tech start-ups. Before Velocity, she was Executive Director, Business Development at GoRemote through IPO. She has also held various roles in international product management and market development for AT&T. She has a B.S. in Civil Engineering from NMSU and an M.B.A. in International Marketing from Pepperdine University. Kristin was named a CNN Principal Voice in Innovation and Technology for 2007. She often speaks as an advocate for how access to technology can change people’s lives in developing countries.